BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23083051)

  • 21. [A case of primary colon amyloidosis presenting as hematochezia].
    Kwon YH; Kim JY; Kim JH; Park HW; Yang HM; Jeon SW; Kim SK
    Korean J Gastroenterol; 2012 Jan; 59(1):44-7. PubMed ID: 22289954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Marked shrinkage of amyloid lymphadenopathy after an intensive chemotherapy in a patient with IgM-associated AL amyloidosis.
    Tazawa K; Katoh N; Shimojima Y; Matsuda M; Ikeda S
    Amyloid; 2009; 16(3):183-5. PubMed ID: 19590992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of primary systemic amyloidosis (AL): role of intensive and standard therapy.
    Sher T; Hayman SR; Gertz MA
    Clin Adv Hematol Oncol; 2012 Oct; 10(10):644-51. PubMed ID: 23187770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary localized cutaneous amyloidosis--lichen amyloidosus. A case report.
    Gałazka K; Bogdaszewska-Czabanowska J; Setkowicz M; Stachura J
    Pol J Pathol; 1999; 50(2):119-22. PubMed ID: 10481537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Amyloidosis in a mixed pattern. Sensitivity to colchicine and melphalan].
    Frustaci A; Gentiloni N; Feoli F
    Minerva Med; 1981 Apr; 72(15):957-60. PubMed ID: 6784038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stiff heart syndrome.
    Arora S; Arora A; Makkar RP; Monga A
    CMAJ; 2003 Jun; 168(13):1690-1. PubMed ID: 12821624
    [No Abstract]   [Full Text] [Related]  

  • 27. Prospective randomized trial of melphalan and prednisone versus vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis.
    Gertz MA; Lacy MQ; Lust JA; Greipp PR; Witzig TE; Kyle RA
    J Clin Oncol; 1999 Jan; 17(1):262-7. PubMed ID: 10458241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary systemic (amyloid light-chain) amyloidosis masquerading as pseudoxanthoma elasticum: recognizing a novel clinicopathological pattern.
    Wat H; Wu DC; Mahmood MN; Brassard A
    JAMA Dermatol; 2014 Oct; 150(10):1091-4. PubMed ID: 24898161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary Systemic Amyloidosis: A Case Report.
    Oli SS; Jha A; Karki A; Sapkota S; Adhikari L
    JNMA J Nepal Med Assoc; 2023 Oct; 61(266):822-824. PubMed ID: 38289775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunomodulatory drugs in the treatment of primary systemic light chain amyloidosis].
    Charliński G; Wiater E; Jedrzejczak WW
    Pol Merkur Lekarski; 2012 Apr; 32(190):217-20. PubMed ID: 22708276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of amyloid myopathy diagnosed during the treatment of myopathy associated with anti-signal recognition particle antibodies].
    Kawakami N; Katsuyama Y; Hagiwara Y; Yoshida H; Kim K; Harada K
    Rinsho Shinkeigaku; 2017 Apr; 57(4):168-173. PubMed ID: 28367947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AL amyloidosis manifesting as systemic lymphadenopathy.
    Matsuda M; Gono T; Shimojima Y; Yoshida T; Katoh N; Hoshii Y; Yamada T; Ikeda S
    Amyloid; 2008 Jun; 15(2):117-24. PubMed ID: 18484338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Penile ulcers complicating systemic AL amyloidosis: a case report.
    Arun M; Sloan SB; Shelton A; Sanchorawala V
    Amyloid; 2016 Sep; 23(3):203-204. PubMed ID: 27187183
    [No Abstract]   [Full Text] [Related]  

  • 34. Primary localised laryngeal amyloidosis.
    Bozkus F; Ulas T; Lynen I; Ozardali I; Sans I
    J Pak Med Assoc; 2013 Mar; 63(3):385-6. PubMed ID: 23914645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Light chain amyloidosis--clinical symptoms, update diagnosis, and treatment].
    Charliński G; Jurczyszyn A; Wiktor-Jedrzejczak W
    Przegl Lek; 2014; 71(2):102-9. PubMed ID: 25016786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutaneous amyloidosis.
    Borowicz J; Gillespie M; Miller R
    Skinmed; 2011; 9(2):96-100; quiz 101. PubMed ID: 21548513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An unusual case of primary systemic amyloidosis.
    Ambrosone L; Mansi L; Salvatore T; Marino F; Orabona P; Rambaldi A; Rambaldi PF; Rambaldi M
    J Eur Acad Dermatol Venereol; 1998 Jan; 10(1):53-7. PubMed ID: 9552758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatal recurrent dermatoneuro syndrome associated with systemic AL amyloidosis.
    Leonardis L; Pihler DN; Zupan M; Vizjak A; Belcijan NL; Jurcic V; Popovic M
    Clin Neuropathol; 2016; 35(2):72-7. PubMed ID: 26754417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of amyloidosis of the large intestine which showed remarkable calcification of the intestinal wall].
    Yamane T; Koido S; Nakamura M; Saito A; Sato Y; Niiya M; Onizawa N; Fujise K; Omura M; Kobayashi M; Toda G
    Nihon Shokakibyo Gakkai Zasshi; 2004 Mar; 101(3):274-80. PubMed ID: 15065347
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical images: Skeletal muscle pseudo-hypertrophy in myeloma-associated amyloidosis.
    Lawson TM; Bevan MA; Williams BD
    Arthritis Rheum; 2002 Aug; 46(8):2251. PubMed ID: 12209535
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.